Last 48 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Masimo Corporation's quarterly P/E stands at 41.0x. EV/EBITDA has expanded 14.7% YoY to 31.5x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -63.75 | 40.96 | 25.08 | — | 44.74 | — | — | 185.00 | 108.57 | 104.89 | 46.51 | 109.60 | 141.85 |
| — | — | — | — | -58.8% | — | — | +68.8% | -23.5% | -11.3% | -5.7% | +117.4% | +37.8% | |
| P/S Ratio | 6.12 | 5.82 | 4.18 | 5.18 | 6.21 | 6.02 | 3.69 | 3.58 | 4.97 | 5.86 | 2.87 | 2.47 | 4.92 |
| — | -3.4% | +13.5% | +44.5% | +25.0% | +2.8% | +28.6% | +45.2% | +1.1% | +31.9% | -12.7% | -29.0% | +47.9% | |
| P/B Ratio | 13.41 | 11.91 | 9.57 | 9.50 | 8.84 | 9.47 | 8.42 | 4.94 | 5.00 | 5.83 | 4.61 | 3.70 | 6.84 |
| — | +25.7% | +13.7% | +92.1% | +76.9% | +62.4% | +82.6% | +33.4% | -27.0% | -22.7% | -23.8% | -39.2% | +9.5% | |
| P/FCF | 47.26 | 55.26 | 32.33 | 37.78 | 35.73 | 82.99 | 46.63 | — | 25.37 | 56.69 | 30.38 | — | 1491.92 |
| — | -33.4% | -30.7% | — | +40.9% | +46.4% | +53.5% | — | -98.3% | — | — | — | — | |
| EV / EBITDA | 27.74 | 31.51 | 18.75 | 21.69 | 33.30 | 27.46 | — | 24.22 | 36.20 | 34.73 | 26.70 | 28.17 | 44.89 |
| — | +14.7% | — | -10.5% | -8.0% | -20.9% | — | -14.0% | -19.4% | -18.1% | +82.6% | -17.8% | +101.0% | |
| EV / EBIT | 31.18 | 31.51 | 22.43 | 23.79 | 38.17 | 30.81 | — | 89.76 | 45.73 | 41.59 | 48.11 | 52.25 | 66.85 |
| — | +2.3% | — | -73.5% | -16.5% | -25.9% | — | +71.8% | -31.6% | -41.7% | +44.5% | +52.5% | +0.2% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Masimo Corporation's operating margin was 19.2% in Q1 2026, down 1.2 pp QoQ and down 1.8 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.9% | 62.1% | 60.0% | 62.1% | 62.9% | 62.9% | 40.7% | 52.2% | 60.3% | 60.8% | 47.9% | 49.0% | 48.6% |
| — | -1.2% | +47.2% | +19.0% | +4.3% | +3.4% | -14.9% | +6.4% | +24.1% | +20.7% | -5.8% | -4.7% | +6.4% | |
| Operating Margin | 20.5% | 19.2% | 20.3% | 22.5% | 17.4% | 21.0% | -59.8% | 6.0% | 12.2% | 15.6% | 8.0% | 5.3% | 6.4% |
| — | -8.5% | +134.0% | +277.3% | +42.7% | +34.1% | -845.8% | +13.4% | +89.3% | +132.5% | -32.5% | -47.3% | +64.6% | |
| Net Margin | -9.9% | 14.1% | 16.6% | -27.0% | 13.8% | -45.9% | -58.2% | 1.9% | 4.7% | 5.6% | 6.2% | 2.2% | 3.4% |
| — | +130.8% | +128.5% | -1491.6% | +197.3% | -924.5% | -1042.3% | -12.3% | +34.9% | +47.6% | -6.8% | -67.9% | +7.7% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -17.1% | 7.6% | 8.9% | -10.8% | 5.2% | -17.1% | -27.8% | 0.7% | 1.2% | 1.4% | 2.6% | 0.8% | 1.2% |
| — | +144.3% | +132.1% | -1665.9% | +340.7% | -1333.9% | -1182.6% | -15.6% | -1.6% | -13.2% | -18.7% | -73.4% | -8.5% | |
| ROA | -7.0% | 3.4% | 3.9% | -4.8% | 2.2% | -6.9% | -12.2% | 0.3% | 0.5% | 0.6% | 1.1% | 0.4% | 0.5% |
| — | +149.2% | +131.7% | -1552.0% | +299.5% | -1201.5% | -1189.7% | -7.1% | +6.7% | -6.4% | -14.0% | -72.0% | -31.1% | |
| ROIC | 16.5% | 5.1% | 5.7% | 4.8% | 3.2% | 3.6% | -13.9% | 1.1% | 1.5% | 1.8% | 1.5% | 0.9% | 1.0% |
| — | +40.1% | +141.1% | +353.0% | +117.0% | +98.3% | -1007.8% | +20.1% | +44.0% | +39.2% | -41.2% | -56.5% | -11.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Masimo Corporation's Debt/EBITDA ratio is 6.3x, up from 5.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 23.5% YoY to 2.68x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.78 | 0.62 | 0.78 | 0.72 | 0.62 | 0.72 | 0.80 | 0.59 | 0.63 | 0.70 | 0.71 | 0.78 | 0.75 |
| — | -14.5% | -3.6% | +23.0% | -2.4% | +2.7% | +13.2% | -24.9% | -16.3% | -7.4% | -7.5% | -5.5% | -9.6% | |
| Debt / EBITDA | 1.59 | 6.28 | 5.74 | 6.39 | 8.81 | 7.87 | — | 10.51 | 16.51 | 15.16 | 14.59 | 20.11 | 18.08 |
| — | -20.2% | — | -39.3% | -46.6% | -48.1% | — | -47.7% | -8.7% | -3.5% | +116.6% | +19.5% | +67.5% | |
| Current Ratio | 2.49 | 2.68 | 2.49 | 2.84 | 2.14 | 2.17 | 1.98 | 2.01 | 2.09 | 2.31 | 2.18 | 2.14 | 2.11 |
| — | +23.5% | +25.6% | +41.3% | +2.6% | -6.3% | -9.2% | -6.1% | -1.0% | +6.9% | +5.2% | +0.8% | +0.7% | |
| Quick Ratio | 1.47 | 1.45 | 1.47 | 1.92 | 1.61 | 1.62 | 1.24 | 1.11 | 1.15 | 1.31 | 1.22 | 1.13 | 1.16 |
| — | -10.5% | +18.3% | +72.4% | +39.5% | +23.5% | +1.9% | -1.3% | -1.0% | +0.7% | -5.0% | -11.7% | -9.4% | |
| Interest Coverage | 9.21 | — | 10.87 | 9.51 | 7.76 | 8.77 | -35.17 | 2.10 | 3.76 | 4.39 | 2.67 | 2.09 | 3.10 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying MASI stock.
Masimo Corporation's current P/E is -63.8x. The average P/E over the last 3 quarters is 36.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Masimo Corporation's current operating margin is 20.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Masimo Corporation's business trajectory between earnings reports.